Olumiant
Payments companies reported to CMS as associated with Olumiant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Olumiant, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Olumiant
These are the largest totals companies reported as associated with Olumiant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Natasha Mesinkovska | Mission Viejo, CA | Procedural Dermatology | $163,779.10 |
| Brett King | Fairfield, CT | Dermatology | $160,566.31 |
| Christina Feser | Clarksville, TN | Dermatology | $157,258.36 |
| Chesahna Kindred Weaver | Marriottsville, MD | Dermatology | $154,278.94 |
| Brittany Craiglow | Fairfield, CT | Dermatology | $147,350.69 |
| Omer Ibrahim | Chicago, IL | Dermatology | $147,236.77 |
| Amylynne Frankel | Spartanburg, SC | Dermatology | $128,415.30 |
| Raja Sivamani | Sacramento, CA | Dermatology | $122,943.41 |
| Julian Mackay-Wiggan | Boynton Beach, FL | Dermatology | $122,058.65 |
| Marc Glashofer | West Orange, NJ | Mohs-Micrographic Surgery | $118,914.76 |
Prescribed Olumiant?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.